Femasys (FEMY) Total Non-Current Liabilities (2020 - 2026)

Femasys (FEMY) posted Total Non-Current Liabilities of $6.1 million for Q1 2026, down 46.07% on a QoQ basis from $11.2 million in Q4 2025, and up 320.16% year-over-year from $1.4 million in Q1 2025.

Femasys (FEMY) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Femasys' Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $6.1 million for Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 320.16% year-over-year to $6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 million (up 320.16% YoY) and the FY2025 annual result came in at $11.2 million, up 620.2% from the prior year.
  • Total Non-Current Liabilities was $6.1 million for Q1 2026 at Femasys, down from $11.2 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $11.2 million in Q4 2025 and bottomed at $56245.0 in Q2 2023.
  • A 5-year average of $3.1 million and a median of $1.4 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 11567.19% — and 2025, when it slumped 82.33%.
  • Femasys' Total Non-Current Liabilities stood at $125242.0 in 2022, then soared by 4969.53% to $6.3 million in 2023, then slumped by 75.47% to $1.6 million in 2024, then surged by 620.2% to $11.2 million in 2025, then slumped by 46.07% to $6.1 million in 2026.
  • Business Quant data shows FEMY's Total Non-Current Liabilities at $6.1 million in Q1 2026, $11.2 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 6.48 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 1.92 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 48.37 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 17.13 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 941.16 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 996.30 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 4.24 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 8.65 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 2.06 Bn
10 Femasys 17.46 Mn 12.07 Mn - 6.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.05 Mn
Dec 31, 2025 11.22 Mn
Sep 30, 2025 1.19 Mn
Jun 30, 2025 1.31 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 1.56 Mn
Sep 30, 2024 6.75 Mn
Jun 30, 2024 6.56 Mn
Mar 31, 2024 6.41 Mn
Dec 31, 2023 6.35 Mn
Sep 30, 2023 2.22 Mn
Jun 30, 2023 56,245.00
Mar 31, 2023 98,818.00
Dec 31, 2022 125,242.00
Sep 30, 2022 217,577.00
Jun 30, 2022 318,237.00
Mar 31, 2022 407,573.00
Dec 31, 2021 552,208.00
Sep 30, 2021 690,767.00
Jun 30, 2021 788,469.00